Total enrollment up 10.2% YoY for fourth quarter 2025

Revenue up 12.9% YoY for fiscal 2025

Fiscal 2025 diluted earnings per share $6.18; Adjusted EPS $6.67, growth of 33.1% YoY

Fourth quarter highlights

Revenue $457.1 million, up 11.5% year-over-year
Total student enrollment 91,780, up 10.2% year-over-year
Chamberlain tenth straight quarter of total enrollment growth, up 5.8% year-over-year
Walden eighth straight quarter of total enrollment growth, up 15.0% year-over-year
Medical and Veterinary sustained total enrollment growth, up 1.0% year-over-year
GAAP net income $54.2 million; adjusted EBITDA $110.2 million, up 13.2% year-over-year

Fiscal year highlights

Revenue $1,788.3 million, up 12.9% year-over-year
Chamberlain achieved record total enrollment, more than 40,500 enrolled
Walden total enrollment up double digits every quarter, achieving more than 48,500 enrolled
Medical and Veterinary approx. 5,000 students enrolled on average
Growth with Purpose momentum, GAAP net income $237.1 million; adjusted EBITDA $459.7 million, up 21.8% year-over-year

Fiscal year capital allocation

Repurchased $211 million of shares completing prior authorization; new $150 million Board authorization through May 2028
Repriced $253 million Term Loan B on Aug. 21, 2024, reducing interest rate by 75 bps; repaid $100 million of outstanding Term Loan B balance on Jan. 17, 2025
Net leverage 0.8x as of June 30, 2025

Fiscal year ‘26 guidance

Revenue $1,900 million to $1,940 million
Adjusted earnings per share $7.60 to $7.90

Adtalem Global Education Inc. (NYSE:ATGE), the leading healthcare educator in the United States, today reported fourth quarter and fiscal 2025 results (ended June 30, 2025), achieving exceptional results through sustained total enrollment growth, increased operational efficiency and strong student outcomes through disciplined strategic execution.

"Fiscal 2025 marked a defining moment for Adtalem—an inflection point that demonstrated the strength and scaled ability of our Growth with Purpose strategy," said Steve Beard, chairman and chief executive officer of Adtalem Global Education. "We delivered strong financial results while deepening our impact—graduating more healthcare professionals into roles where they're urgently needed. Our disciplined investments and student outcomes, coupled with strategic partnerships, are creating repeatable high return pathways from education to employment. With a resilient operating model and growing momentum, we are well-positioned to sustain performance and deliver long-term value for our students, shareholders and the U.S. healthcare system."

Financial Highlights

Selected financial data for the three months ended June 30, 2025:

Revenue was $457.1 million, an increase of 11.5% compared with the prior year.
Operating income was $76.9 million, compared with $68.5 million in the prior year; adjusted operating income was $87.5 million, compared with $80.1 million in the prior year.
Net income was $54.2 million, compared with $49.4 million in the prior year; adjusted net income was $62.4 million, compared with $52.8 million in the prior year.
Diluted earnings per share was $1.44, compared with $1.28 in the prior year; adjusted earnings per share was $1.66, compared with $1.37 in the prior year.
Adjusted EBITDA was $110.2 million, compared with $97.4 million in the prior year; adjusted EBITDA margin was 24.1%, compared with 23.8% in the prior year.

Selected financial data for the fiscal year ended June 30, 2025:

Revenue was $1,788.3 million, an increase of 12.9% compared with the prior year.
Operating income was $341.5 million, compared with $217.1 million in the prior year; adjusted operating income was $370.2 million, compared with $308.8 million in the prior year.
Net income was $237.1 million, compared with $136.8 million in the prior year; adjusted net income was $255.6 million, compared with $201.8 million in the prior year.
Diluted earnings per share was $6.18, compared with $3.39 in the prior year; adjusted earnings per share was $6.67, compared with $5.01 in the prior year.
Adjusted EBITDA was $459.7 million, compared with $377.5 million in the prior year; adjusted EBITDA margin was 25.7%, compared with 23.8% in the prior year.

Business Highlights

Chamberlain University and SSM Health announced the Aspiring Nurse Program – a groundbreaking partnership designed to address critical healthcare workforce needs. The innovative partnership funds nursing education¹, enhances clinical readiness and creates a pathway to employment across SSM Health's care sites in Missouri, Oklahoma, Illinois and Wisconsin. The partnership offers a direct, employment-focused pathway for aspiring nurses, creating a sustainable talent pipeline that will graduate more than 400 new nurses annually.
Walden University and Chamberlain University earned the prestigious "Opportunity Colleges and Universities" designation in the 2025 Carnegie Classification. This selective recognition from the Carnegie Foundation and American Council on Education, awarded to only 16% of institutions assessed, confirms Chamberlain and Walden's ability to serve broad student populations while delivering strong economic outcomes for graduates.
Walden University's Doctor of Social Work (DSW) program has achieved accreditation by the Council on Social Work Education (CSWE), making it one of only four DSW programs in the U.S. to receive this recognition. This accreditation validates the quality of the DSW program and the professional excellence of its graduates.
Adtalem's Medical and Veterinary schools (American University of the Caribbean School of Medicine, Ross University School of Medicine and Ross University School of Veterinary Medicine) graduated more than 1,100 students in fiscal year 2025. Medical students from 42 states and 30 countries and veterinary students from 43 states and four countries were amongst the graduating class.²
American University of the Caribbean School of Medicine (AUC) has collaborated with Massachusetts General Hospital Institute of Health Professions (MGH Institute of Health Professions) to create the MGHIHP-AUC-Gateway for Innovation Careers in Medical Technology ("MAGIC") partnership, providing AUC students the ability to pursue a Master's in Healthcare Data Analytics (MSDA) which can be completed while students complete their Doctor of Medicine (MD) degree. The partnership places AUC students and alumni at the forefront of the AI digital transformation in healthcare, shaping the future of medicine.

Segment Highlights

Chamberlain

$ in millions	Three Months Ended June 30,			Year Ended June 30,
	2025	2024	% Change	2025	2024	% Change
Revenue	$184.3	$167.0	10.3%	$725.8	$633.5	14.6%
Operating Income	$35.7	$40.5	(11.7)%	$151.5	$137.8	9.9%
Adj. Operating Income	$35.7	$40.5	(11.7)%	$153.4	$137.8	11.3%
Adj. EBITDA	$45.0	$47.3	(4.8)%	$191.4	$166.2	15.2%
Total Students ⁽³⁾	38,891	36,750	5.8%

Total student enrollment increased 5.8% compared with the prior year, driven by continued growth in pre-licensure and post-licensure nursing programs.

Walden

$ in millions	Three Months Ended June 30,			Year Ended June 30,
	2025	2024	% Change	2025	2024	% Change
Revenue	$182.2	$156.3	16.6%	$693.4	$595.3	16.5%
Operating Income	$44.0	$30.1	46.3%	$177.9	$77.2	130.5%
Adj. Operating Income	$46.8	$37.4	25.1%	$183.6	$130.5	40.6%
Adj. EBITDA	$52.7	$41.1	28.0%	$206.5	$146.8	40.7%
Total Students ⁽³⁾	48,116	41,845	15.0%

Total student enrollment increased 15.0% compared with the prior year, driven by growth in healthcare and non-healthcare programs.

Medical and Veterinary

$ in millions	Three Months Ended June 30,			Year Ended June 30,
	2025	2024	% Change	2025	2024	% Change
Revenue	$90.6	$86.6	4.7%	$369.1	$355.8	3.7%
Operating Income	$14.9	$11.9	24.7%	$68.8	$71.1	(3.2)%
Adj. Operating Income	$15.1	$12.0	25.8%	$69.3	$71.5	(3.2)%
Adj. EBITDA	$20.0	$16.5	21.7%	$88.8	$88.9	(0.1)%
Total Students ⁽³⁾	4,773	4,726	1.0%

Total student enrollment increased 1.0% compared with the prior year, driven by growth at medical and veterinary.

Fiscal Year 2026 Outlook

Adtalem initiates guidance for fiscal year 2026, revenue in the range of $1,900 million to $1,940 million, approximately 6.0% to 8.5% growth year-over-year. Adjusted earnings per share to be in the range of $7.60 to $7.90, approximately 14.0% to 18.5% growth year-over-year.

Conference Call and Webcast Information

Adtalem will hold a conference call to discuss its fourth quarter and fiscal year 2025 results today at 4:00 p.m. CT (5:00 p.m. ET).

The call can be accessed by dialing +1 877-407-6184 (U.S. participants) or +1 201-389-0877 (international participants) and stating "Adtalem earnings call" or by using conference ID: 13754556. The call will be simulcast through the Adtalem investor relations website at: https://investors.adtalem.com.

Adtalem will archive a replay of the call for 30 days. To access the replay, dial +1 877-660-6853 (U.S.) or +1 201-612-7415 (international), conference ID: 13754556, or visit the Adtalem investor relations website.

About Adtalem Global Education

Adtalem Global Education is the leading provider of healthcare education in the U.S., shaping the future of healthcare by preparing a workforce with high-quality academic programs. We innovate education pathways, align with industry needs and empower individuals to reach their full potential. Our commitment to excellence and access is reflected in our expansive network of institutions, serving over 90,000 students and supported by a strong community of approximately 365,000 alumni and nearly 10,000 dedicated employees. Visit Adtalem.com for more information and follow us on LinkedIn, Instagram and Facebook.

Cautionary Disclosure Regarding Forward-Looking Statements

Certain statements contained in this release are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact, which includes statements regarding Adtalem's future growth. Forward-looking statements generally can be identified by the use of forward-looking terminology such as "future," "believe," "project," "expect," "anticipate," "estimate," "plan," "intend," "may," "will," "would," "could," "can," "continue," "preliminary," "potential," "range," and similar terms. These forward-looking statements are subject to risk and uncertainties that could cause actual results to differ materially from those described in the statements. Important factors that could cause actual results to differ materially from the expectations expressed or implied by our forward-looking statements are disclosed in Item 1A. "Risk Factors," of our Annual Report on Form 10-K. You should evaluate forward-looking statements in the context of these risks and uncertainties and are cautioned to not place undue reliance on such forward-looking statements. We caution you that these factors, performance or developments we expect or anticipate or, even if substantially realized, that they will result in the consequences or affect us or our operations in the way we expect. All forward-looking statements are based on information available to use as of the date any such statements are made, and Adtalem assumes no obligation to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results expressed or implied therein will not be realized, except as required by law.

A reconciliation of non-GAAP guidance measures to corresponding GAAP measures is not available on a forward-looking basis without unreasonable effort due to the uncertainty of special items that may be incurred in the future, although these special items could be material to Adtalem's results in accordance with GAAP.

¹ For students who apply and qualify after graduating, passing NCLEX and fulfilling employment obligations with SSM Health of up to 4 years. Full coverage requires funding 100% of tuition and fees with student loans.

² States include the District of Columbia; countries based on student citizenship.

³ Represents total students attending sessions during each institution's most recent enrollment period in Q4 FY 2025 and Q4 FY 2024.

Adtalem Global Education Inc. Consolidated Balance Sheets (unaudited) (in thousands, except par value)

	June 30,
	2025		2024
Assets:
Current assets:
Cash and cash equivalents	$	199,601	$	219,306
Restricted cash		1,563		1,896
Accounts and financing receivables, net		146,189		126,833
Prepaid expenses and other current assets		68,837		70,050
Total current assets		416,190		418,085
Noncurrent assets:
Property and equipment, net		256,131		248,524
Operating lease assets		191,194		176,755
Deferred income taxes		32,956		49,088
Intangible assets, net		765,474		776,694
Goodwill		961,262		961,262
Other assets, net		129,145		103,184
Assets held for sale		—		7,825
Total noncurrent assets		2,336,162		2,323,332
Total assets	$	2,752,352	$	2,741,417
Liabilities and shareholders' equity:
Current liabilities:
Accounts payable	$	105,017	$	102,626
Accrued payroll and benefits		76,374		71,373
Accrued liabilities		77,286		96,957
Deferred revenue		214,091		185,272
Current operating lease liabilities		35,159		31,429
Total current liabilities		507,927		487,657
Noncurrent liabilities:
Long-term debt		552,669		648,712
Long-term operating lease liabilities		186,172		167,712
Deferred income taxes		31,856		29,526
Other liabilities		40,103		38,675
Total noncurrent liabilities		810,800		884,625
Total liabilities		1,318,727		1,372,282
Commitments and contingencies
Total shareholders' equity		1,433,625		1,369,135
Total liabilities and shareholders' equity	$	2,752,352	$	2,741,417

Adtalem Global Education Inc. Consolidated Statements of Income (unaudited) (in thousands, except per share data)

	Three Months Ended						Year Ended
	June 30,						June 30,
	2025			2024			2025			2024
Revenue	$	457,106		$	409,907		$	1,788,290		$	1,584,652
Operating cost and expense:
Cost of educational services		198,930			182,540			771,430			698,548
Student services and administrative expense		180,863			154,597			672,004			632,965
Restructuring expense		388			653			3,314			1,870
Business integration expense		—			3,594			—			34,215
Total operating cost and expense		380,181			341,384			1,446,748			1,367,598
Operating income		76,925			68,523			341,542			217,054
Interest expense		(10,853	)		(14,749	)		(52,318	)		(63,659	)
Other income, net		2,511			1,894			9,290			10,542
Income from continuing operations before income taxes		68,583			55,668			298,514			163,937
Provision for income taxes		(14,121	)		(5,068	)		(65,837	)		(26,224	)
Income from continuing operations		54,462			50,600			232,677			137,713
Discontinued operations:
(Loss) income from discontinued operations before income taxes		(346	)		(1,091	)		5,870			(762	)
Benefit from (provision for) income taxes		96			(90	)		(1,482	)		(174	)
(Loss) income from discontinued operations		(250	)		(1,181	)		4,388			(936	)
Net income and comprehensive income	$	54,212		$	49,419		$	237,065		$	136,777

Earnings (loss) per share:
Basic:
Continuing operations	$	1.51		$	1.34		$	6.27		$	3.49
Discontinued operations	$	(0.01	)	$	(0.03	)	$	0.12		$	(0.02	)
Total basic earnings per share	$	1.50		$	1.31		$	6.39		$	3.47
Diluted:
Continuing operations	$	1.45		$	1.31		$	6.07		$	3.42
Discontinued operations	$	(0.01	)	$	(0.03	)	$	0.11		$	(0.02	)
Total diluted earnings per share	$	1.44		$	1.28		$	6.18		$	3.39

Weighted-average shares outstanding:
Basic shares		36,034			37,642			37,085			39,413
Diluted shares		37,584			38,595			38,334			40,307

Adtalem Global Education Inc. Consolidated Statements of Cash Flows (unaudited) (in thousands)

	Year Ended June 30,
	2025			2024
Operating activities:
Net income	$	237,065		$	136,777
(Income) loss from discontinued operations		(4,388	)		936
Income from continuing operations		232,677			137,713
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation		41,590			25,947
Amortization and impairments to operating lease assets		32,543			32,641
Depreciation		40,702			39,676
Amortization of acquired intangible assets		11,220			35,644
Amortization and write-off of debt discount and issuance costs		5,985			5,663
Provision for bad debts		63,237			53,175
Deferred income taxes		18,413			11,073
Loss on disposals and impairments of property and equipment		2,527			466
Gain on investments		(1,074	)		(1,365	)
Loss on assets held for sale		490			647
Changes in assets and liabilities:
Accounts and financing receivables		(80,820	)		(76,355	)
Prepaid expenses and other current assets		5,546			(8,781	)
Cloud computing implementation assets		(32,823	)		(27,154	)
Accounts payable		140			18,330
Accrued payroll and benefits		5,144			19,422
Accrued liabilities		(15,948	)		27,422
Deferred revenue		34,273			40,622
Operating lease liabilities		(24,792	)		(36,692	)
Other assets and liabilities		(5,296	)		(9,727	)
Net cash provided by operating activities-continuing operations		333,734			288,367
Net cash provided by operating activities-discontinued operations		4,165			7,408
Net cash provided by operating activities		337,899			295,775
Investing activities:
Capital expenditures		(50,327	)		(48,893	)
Proceeds from sales of marketable securities		3,120			1,732
Purchases of marketable securities		(2,048	)		(689	)
Proceeds from sale of assets		7,334			—
Net cash used in investing activities-continuing operations		(41,921	)		(47,850	)
Financing activities:
Proceeds from exercise of stock options		10,027			17,089
Employee taxes paid on withholding shares		(14,200	)		(7,731	)
Proceeds from stock issued under Colleague Stock Purchase Plan		1,282			810
Repurchases of common stock for treasury		(213,125	)		(261,966	)
Proceeds from issuance of long-term debt		9,873			1,896
Repayments of long-term debt		(109,873	)		(51,896	)
Net cash used in financing activities		(316,016	)		(301,798	)
Net decrease in cash, cash equivalents and restricted cash		(20,038	)		(53,873	)
Cash, cash equivalents and restricted cash at beginning of period		221,202			275,075
Cash, cash equivalents and restricted cash at end of period	$	201,164		$	221,202

Adtalem Global Education Inc. Segment Revenue (unaudited) (in thousands)

	Three Months Ended								Year Ended
	June 30,								June 30,
					Increase/(Decrease)								Increase/(Decrease)
	2025		2024		$		%		2025		2024		$		%
Revenue:
Chamberlain	$	184,266	$	167,035	$	17,231	10.3	%	$	725,774	$	633,522	$	92,252	14.6	%
Walden		182,193		156,309		25,884	16.6	%		693,430		595,332		98,098	16.5	%
Medical and Veterinary		90,647		86,563		4,084	4.7	%		369,086		355,798		13,288	3.7	%
Total consolidated revenue	$	457,106	$	409,907	$	47,199	11.5	%	$	1,788,290	$	1,584,652	$	203,638	12.9	%

Adtalem Global Education Inc.

Non-GAAP Financial Measures and Reconciliations

We believe that certain non-GAAP financial measures provide investors with useful supplemental information regarding the underlying business trends and performance of Adtalem's ongoing operations as seen through the eyes of management and are useful for period-over-period comparisons. We use these supplemental non-GAAP financial measures internally in our assessment of performance and budgeting process. However, these non-GAAP financial measures should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. The following are non-GAAP financial measures used in the subsequent GAAP to non-GAAP reconciliation tables:

Adjusted net income (most comparable GAAP measure: net income) – Measure of Adtalem's net income adjusted for restructuring expense, business integration expense, amortization of acquired intangible assets, write-off of debt discount and issuance costs, litigation reserve, asset impairments, loss on assets held for sale, debt modification costs, strategic advisory costs, tax benefit due to change in unrecognized tax benefits, and loss (income) from discontinued operations.

Adjusted earnings per share (most comparable GAAP measure: diluted earnings per share) – Measure of Adtalem's diluted earnings per share adjusted for restructuring expense, business integration expense, amortization of acquired intangible assets, write-off of debt discount and issuance costs, litigation reserve, asset impairments, loss on assets held for sale, debt modification costs, strategic advisory costs, tax benefit due to change in unrecognized tax benefits, and loss (income) from discontinued operations.

Adjusted operating income (most comparable GAAP measure: operating income) – Measure of Adtalem's operating income adjusted for restructuring expense, business integration expense, amortization of acquired intangible assets, litigation reserve, asset impairments, strategic advisory costs, loss on assets held for sale, and debt modification costs.

Adjusted EBITDA (most comparable GAAP measure: net income) – Measure of Adtalem's net income adjusted for loss (income) from discontinued operations, interest expense, other income, net, provision for income taxes, depreciation, amortization of acquired intangible assets, amortization of cloud computing implementation assets, stock-based compensation, restructuring expense, business integration expense, litigation reserve, asset impairments, strategic advisory costs, loss on assets held for sale, and debt modification costs. Provision for income taxes, interest expense, and other income, net is not recorded at the reportable segments, and therefore, the segment adjusted EBITDA reconciliations begin with adjusted operating income.

Free cash flow (most comparable GAAP measure: net cash provided by operating activities-continuing operations) – Defined as net cash provided by operating activities-continuing operations less capital expenditures.

Net debt – Defined as long-term debt less cash and cash equivalents.

Net leverage – Defined as net debt divided by adjusted EBITDA.

A description of special items in our non-GAAP financial measures described above are as follows:

Restructuring expense primarily related to workforce reductions, costs to exit certain course offerings, and prior real estate consolidations at Adtalem's home office. We do not include normal, recurring, cash operating expenses in our restructuring expense.
Business integration expense includes expenses related to the Walden acquisition and certain costs related to growth transformation initiatives. We do not include normal, recurring, cash operating expenses in our business integration expense.
Amortization of acquired intangible assets.
Amortization of cloud computing implementation assets.
Write-off of debt discount and issuance costs related to prepayments of debt, reserves related to significant litigation, asset impairments related to adjusting certain operating lease assets and property and equipment as a result of adjusting carrying values to fair values, loss on assets held for sale related to adjusting those assets to estimated fair value less costs to sell, and debt modification costs related to refinancing our Term Loan B loan.
Strategic advisory costs related to expanding capabilities and bringing new capacities to market to further enhance our strategic position. We do not include normal, recurring, cash operating expenses in our strategic advisory costs.
Tax benefit due to change in unrecognized tax benefits.
Loss (income) from discontinued operations includes expense from ongoing litigation costs and settlements related to divestitures and the earn-outs we received.

Adtalem Global Education Inc. Adjusted Operating Income (unaudited) (in thousands)

	Three Months Ended														Year Ended
	June 30,														June 30,
									Increase/(Decrease)														Increase/(Decrease)
	2025				2024				$			%			2025				2024				$			%
Chamberlain:
Operating income	$	35,739			$	40,487			$	(4,748	)	(11.7	)	%	$	151,455			$	137,800			$	13,655		9.9		%
Restructuring expense		—				—				—						1,912				—				1,912
Adjusted operating income	$	35,739			$	40,487			$	(4,748	)	(11.7	)	%	$	153,367			$	137,800			$	15,567		11.3		%
Operating margin		19.4		%		24.2		%								20.9		%		21.8		%
Adjusted operating margin		19.4		%		24.2		%								21.1		%		21.8		%

Walden:
Operating income	$	43,982			$	30,058			$	13,924		46.3		%	$	177,911			$	77,179			$	100,732		130.5		%
Restructuring expense		—				—				—						—				(776	)			776
Amortization of acquired intangible assets		2,805				7,348				(4,543	)					11,220				35,644				(24,424	)
Litigation reserve		—				—				—						(5,550	)			18,500				(24,050	)
Adjusted operating income	$	46,787			$	37,406			$	9,381		25.1		%	$	183,581			$	130,547			$	53,034		40.6		%
Operating margin		24.1		%		19.2		%								25.7		%		13.0		%
Adjusted operating margin		25.7		%		23.9		%								26.5		%		21.9		%

Medical and Veterinary:
Operating income	$	14,864			$	11,923			$	2,941		24.7		%	$	68,798			$	71,065			$	(2,267	)	(3.2	)	%
Restructuring expense		218				63				155						454				442				12
Adjusted operating income	$	15,082			$	11,986			$	3,096		25.8		%	$	69,252			$	71,507			$	(2,255	)	(3.2	)	%
Operating margin		16.4		%		13.8		%								18.6		%		20.0		%
Adjusted operating margin		16.6		%		13.8		%								18.8		%		20.1		%

Home Office:
Operating loss	$	(17,660	)		$	(13,945	)		$	(3,715	)	(26.6	)	%	$	(56,622	)		$	(68,990	)		$	12,368		17.9		%
Restructuring expense		170				590				(420	)					948				2,204				(1,256	)
Business integration expense		—				3,594				(3,594	)					—				34,215				(34,215	)
Asset impairments		—				—				—						6,442				—				6,442
Strategic advisory costs		6,900				—				6,900						12,000				—				12,000
Loss on assets held for sale		490				—				490						490				647				(157	)
Debt modification costs		—				—				—						712				848				(136	)
Adjusted operating loss	$	(10,100	)		$	(9,761	)		$	(339	)	(3.5	)	%	$	(36,030	)		$	(31,076	)		$	(4,954	)	(15.9	)	%

Adtalem Global Education:
Operating income (GAAP)	$	76,925			$	68,523			$	8,402		12.3		%	$	341,542			$	217,054			$	124,488		57.4		%
Restructuring expense		388				653				(265	)					3,314				1,870				1,444
Business integration expense		—				3,594				(3,594	)					—				34,215				(34,215	)
Amortization of acquired intangible assets		2,805				7,348				(4,543	)					11,220				35,644				(24,424	)
Litigation reserve		—				—				—						(5,550	)			18,500				(24,050	)
Asset impairments		—				—				—						6,442				—				6,442
Strategic advisory costs		6,900				—				6,900						12,000				—				12,000
Loss on assets held for sale		490				—				490						490				647				(157	)
Debt modification costs		—				—				—						712				848				(136	)
Adjusted operating income (non-GAAP)	$	87,508			$	80,118			$	7,390		9.2		%	$	370,170			$	308,778			$	61,392		19.9		%
Operating margin (GAAP)		16.8		%		16.7		%								19.1		%		13.7		%
Adjusted operating margin (non-GAAP)		19.1		%		19.5		%								20.7		%		19.5		%

Adtalem Global Education Inc. Adjusted EBITDA (unaudited) (in thousands)

	Three Months Ended														Year Ended
	June 30,														June 30,
									Increase/(Decrease)														Increase/(Decrease)
	2025				2024				$			%			2025				2024				$			%
Chamberlain:
Adjusted operating income (GAAP)	$	35,739			$	40,487			$	(4,748	)	(11.7	)	%	$	153,367			$	137,800			$	15,567		11.3		%
Depreciation		5,503				4,912				591						21,687				18,752				2,935
Amortization of cloud computing implementation assets		780				382				398						3,033				1,332				1,701
Stock-based compensation		3,019				1,512				1,507						13,309				8,303				5,006
Adjusted EBITDA (non-GAAP)	$	45,041			$	47,293			$	(2,252	)	(4.8	)	%	$	191,396			$	166,187			$	25,209		15.2		%
Adjusted EBITDA margin (non-GAAP)		24.4		%		28.3		%								26.4		%		26.2		%

Walden:
Adjusted operating income (GAAP)	$	46,787			$	37,406			$	9,381		25.1		%	$	183,581			$	130,547			$	53,034		40.6		%
Depreciation		1,993				1,654				339						7,421				7,389				32
Amortization of cloud computing implementation assets		760				385				375						3,002				1,331				1,671
Stock-based compensation		3,123				1,703				1,420						12,477				7,525				4,952
Adjusted EBITDA (non-GAAP)	$	52,663			$	41,148			$	11,515		28.0		%	$	206,481			$	146,792			$	59,689		40.7		%
Adjusted EBITDA margin (non-GAAP)		28.9		%		26.3		%								29.8		%		24.7		%

Medical and Veterinary:
Adjusted operating income (GAAP)	$	15,082			$	11,986			$	3,096		25.8		%	$	69,252			$	71,507			$	(2,255	)	(3.2	)	%
Depreciation		2,755				3,086				(331	)					10,853				11,983				(1,130	)
Amortization of cloud computing implementation assets		306				138				168						1,208				469				739
Stock-based compensation		1,873				1,243				630						7,486				4,930				2,556
Adjusted EBITDA (non-GAAP)	$	20,016			$	16,453			$	3,563		21.7		%	$	88,799			$	88,889			$	(90	)	(0.1	)	%
Adjusted EBITDA margin (non-GAAP)		22.1		%		19.0		%								24.1		%		25.0		%

Home Office:
Adjusted operating loss	$	(10,100	)		$	(9,761	)		$	(339	)	(3.5	)	%	$	(36,030	)		$	(31,076	)		$	(4,954	)	(15.9	)	%
Depreciation		184				145				39						741				1,552				(811	)
Stock-based compensation		2,394				2,084				310						8,318				5,189				3,129
Adjusted EBITDA	$	(7,522	)		$	(7,532	)		$	10		0.1		%	$	(26,971	)		$	(24,335	)		$	(2,636	)	(10.8	)	%

Adtalem Global Education:
Net income (GAAP)	$	54,212			$	49,419			$	4,793		9.7		%	$	237,065			$	136,777			$	100,288		73.3		%
Loss (income) from discontinued operations		250				1,181				(931	)					(4,388	)			936				(5,324	)
Interest expense		10,853				14,749				(3,896	)					52,318				63,659				(11,341	)
Other income, net		(2,511	)			(1,894	)			(617	)					(9,290	)			(10,542	)			1,252
Provision for income taxes		14,121				5,068				9,053						65,837				26,224				39,613
Depreciation and amortization		15,086				18,050				(2,964	)					59,165				78,452				(19,287	)
Stock-based compensation		10,409				6,542				3,867						41,590				25,947				15,643
Restructuring expense		388				653				(265	)					3,314				1,870				1,444
Business integration expense		—				3,594				(3,594	)					—				34,215				(34,215	)
Litigation reserve		—				—				—						(5,550	)			18,500				(24,050	)
Asset impairments		—				—				—						6,442				—				6,442
Strategic advisory costs		6,900				—				6,900						12,000				—				12,000
Loss on assets held for sale		490				—				490						490				647				(157	)
Debt modification costs		—				—				—						712				848				(136	)
Adjusted EBITDA (non-GAAP)	$	110,198			$	97,362			$	12,836		13.2		%	$	459,705			$	377,533			$	82,172		21.8		%
Adjusted EBITDA margin (non-GAAP)		24.1		%		23.8		%								25.7		%		23.8		%

Adtalem Global Education Inc. Adjusted Earnings (unaudited) (in thousands, except per share data)

	Three Months Ended						Year Ended
	June 30,						June 30,
	2025			2024			2025			2024
Net income (GAAP)	$	54,212		$	49,419		$	237,065		$	136,777
Restructuring expense		388			653			3,314			1,870
Business integration expense		—			3,594			—			34,215
Amortization of acquired intangible assets		2,805			7,348			11,220			35,644
Write-off of debt discount and issuance costs, litigation reserve, asset impairments, loss on assets held for sale, and debt modification costs		490			—			3,832			21,108
Strategic advisory costs		6,900			—			12,000			—
Tax benefit due to change in unrecognized tax benefits		—			(5,657	)		—			(5,657	)
Income tax impact on non-GAAP adjustments ⁽¹⁾		(2,602	)		(3,749	)		(7,423	)		(23,104	)
Loss (income) from discontinued operations		250			1,181			(4,388	)		936
Adjusted net income (non-GAAP)	$	62,443		$	52,789		$	255,620		$	201,789
⁽¹⁾ Represents the income tax impact of non-GAAP continuing operations adjustments that is recognized in our GAAP financial statements.


	Three Months Ended						Year Ended
	June 30,						June 30,
	2025			2024			2025			2024
Diluted earnings per share (GAAP)	$	1.44		$	1.28		$	6.18		$	3.39
Effect on diluted earnings per share:
Restructuring expense		0.01			0.02			0.09			0.05
Business integration expense		—			0.09			—			0.85
Amortization of acquired intangible assets		0.07			0.19			0.29			0.88
Write-off of debt discount and issuance costs, litigation reserve, asset impairments, loss on assets held for sale, and debt modification costs		0.01			—			0.10			0.52
Strategic advisory costs		0.18			—			0.31			—
Tax benefit due to change in unrecognized tax benefits		—			(0.15	)		—			(0.14	)
Income tax impact on non-GAAP adjustments ⁽¹⁾		(0.07	)		(0.10	)		(0.19	)		(0.57	)
Loss (income) from discontinued operations		0.01			0.03			(0.11	)		0.02
Adjusted earnings per share (non-GAAP)	$	1.66		$	1.37		$	6.67		$	5.01
Diluted shares used in non-GAAP EPS calculation		37,584			38,595			38,334			40,307
Note: May not sum due to rounding. ⁽¹⁾ Represents the income tax impact of non-GAAP continuing operations adjustments that is recognized in our GAAP financial statements.

Adtalem Global Education Inc. Free Cash Flow (unaudited) (in thousands)

	Twelve Months Ended
	FY24			FY25			FY25			FY25			FY25
	Q4			Q1			Q2			Q3			Q4
Net cash provided by operating activities-continuing operations (GAAP)	$	288,367		$	291,820		$	281,971		$	335,069		$	333,734
Capital expenditures		(48,893	)		(48,873	)		(50,375	)		(47,914	)		(50,327	)
Free cash flow (non-GAAP)	$	239,474		$	242,947		$	231,596		$	287,155		$	283,407

Adtalem Global Education Inc. Net Leverage (unaudited) (in thousands)

	Year Ended
	June 30, 2025
Adtalem Global Education:
Net income (GAAP)	$	237,065
Net income from discontinued operations		(4,388	)
Interest expense		52,318
Other income, net		(9,290	)
Provision for income taxes		65,837
Depreciation and amortization		59,165
Stock-based compensation		41,590
Restructuring expense		3,314
Litigation reserve		(5,550	)
Asset impairments		6,442
Strategic advisory costs		12,000
Loss on assets held for sale		490
Debt modification costs		712
Adjusted EBITDA (non-GAAP)	$	459,705

	June 30, 2025
Long-term debt	$	558,283
Less: Cash and cash equivalents		(199,601	)
Net debt (non-GAAP)	$	358,682

Net leverage (non-GAAP)		0.8 x

View source version on businesswire.com: https://www.businesswire.com/news/home/20250807739890/en/

Investor Contact: Jay Spitzer

Investor.Relations@Adtalem.com

+1 312-906-6600

Media Contact: Jason Carr

AdtalemMedia@Adtalem.com

+1 773-858-7932

Adtalem Global Education Announces Exceptional Fiscal Year 2025 Results; Initiates Fiscal Year 2026 Guidance